NIH Funding · FY2024
Total Funding
$1.4M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#10,089
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.4M across 1 grant · National rank #10089.
Top grants by award amount
Kevin Strange's NIH grant portfolio, ranked by award amount.
- 1R44HL174171-01R44IND-enabling safety and toxicity testing of a subcutaneous formulation of the PTP1B inhibitor MSI-1436, a novel strategy for treating fatal cardiomyopathy in Duchenne muscular dystrophy patients$1.4Maward amount
Affiliation
Institutions that have administered grants for Kevin Strange.
Affiliated with Revidia Therapeutics, Inc (ME).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardRevidia Therapeutics, Inc
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
Explore further
Find collaborators for Kevin Strange
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Revidia Therapeutics, Inc
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →